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To the Editor: Diabetes mellitus (DM) is a worldwide public
health problem, made more acute in Africa by low socio-
economic standards. Evidence is also accumulating that dietary
factors such as compromised micronutrient or antioxidant
status may be aetiological or predisposing factors in DM and
complications associated with DM.1 The aim of this study was
to determine the possible role of nutrient intake in the
aetiology of DM.
One hundred and three subjects (72 female and 31 male) who
showed impaired glucose tolerance (IGT) according to the 1985
World Health Organisation (WHO) criteria2 in 1991 were
reinvestigated after 4 years. Seventy-eight subjects (55 female
and 23 male) took part in the follow-up study. Of the
remaining 25 subjects, 12 died, 4 left the area, 6 chose not to
participate and 3 were too ill to participate in the study. Body
mass index (BMI) and body fat percentage were determined
using bioimpedence (Bodystat) in both the baseline and follow-
up studies. Two registered dieticians assessed dietary intake by
means of a quantitative food frequency questionnaire. Food
models and household measures were used as visual aids to
quantify food intake. Dietary data were analysed for nutrients
using a mainframe computer program based on the Research
Institute for Nutritional Diseases (RIND) Food Composition
Tables.3 Nutrient intake was calculated as a percentage of the
US recommended dietary allowances (RDA).4 IGT was based
on a 120-minute stimulated plasma glucose concentration of 7.8
- 11.1 mmol/l after 75 g of oral glucose. Fasting serum albumin
concentrations were also determined.
Of the 78 subjects with IGT, 12 (15.4%, median BMI 29.2
kg/m2, median age 56.2 years) became diabetic (DM group), 26
(33.3%, median BMI 29.6 kg/m2, median age 56.8 years)
remained in the IGT category (IGT group), and 40 (51.2%,
median BMI 27.0 kg/m2, median age 49.9 years) reverted back
to normal glucose tolerance status (NG group). Over the 4-year
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Are low aminoglycoside doses appropriate when used for
perioperative prophylaxis in urology?
To the Editor: Peri-operative antibiotic prophylaxis before
urological  surgery reduces the risk of postoperative urinary
tract infection.1-3 When used in this setting, aminoglycosides
are an appropriate choice to prevent infections caused by
enteric Gram-negative bacilli. However, prophylactic doses
employed are often low, and we feel it appropriate to raise a
few points regarding aminoglycoside dosage regimens in this
context.
The use of higher aminoglycoside doses once daily has
gained widespread acceptance.4 Aminoglycosides demonstrate
concentration-dependent killing of bacteria — the higher peak
level, the more rapid the bactericidal activity. Additionally,
aminoglycosides exhibit a post-antibiotic effect: bacterial
growth is inhibited even when serum antibiotic levels fall to
below the minimum inhibitory concentration of that organism.
A single daily dose reduces the risk of toxicity since lower
trough levels are maintained for longer. Therefore, once-daily
doses of aminoglycosides maintain the efficacy of the
antibiotic, while reducing the potential risk of side-effects.5,6
When using aminoglycosides perioperatively for urological
prophylaxis, it would seem logical to use a once-off standard
dose (such as 5 - 7 mg/kg/day for gentamicin). Currently,
some regimens utilise gentamicin doses as low as 80 mg7,8
(equating to about 1 mg/kg), possibly because of concerns
about aminoglycoside toxicity. Although aminoglycosides are
concentrated in the urine,9 serum levels attained using these
low doses would almost certainly be subtherapeutic. Therefore,
if there are concerns about toxicity, an alternative agent such as
a quinolone could be employed.3 However, in otherwise
healthy individuals we cannot see the rationale behind using
low doses of aminoglycosides as perioperative prophylaxis in
urological surgery.
A Whitelaw
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period a reduction in median BMI was observed: –2.4 kg/m2
for the DM group, –1.9 kg/m2 for the IGT group and –0.6
kg/m2 for the NG group. Table I shows median intakes of
nutrients in the three groups. Subjects in all three groups
showed low median intakes of nutrients (< 67% of the RDAs).
Significantly fewer subjects in the NG group showed low
intakes of ascorbic acid (p = 0.05) than the DM group.
Furthermore, significantly fewer subjects in the NG group
showed low intakes of phosphorus (p = 0.05), folic acid (p =
0.004), ascorbid acid (p = 0.02) and vitamin D (p = 0.05) than
the IGT group. The IGT group showed a significantly lower fat
percentage (p = 0.04) and lean body mass (p = 0.04) than the
NG group. Serum albumin levels in the three groups did not
differ significantly.
Although the presence of IGT and DM might also have
caused suboptimal nutritional status, our results showed that
more subjects in the NG group were better nourished with
regard to certain micronutrients than the IGT and DM groups.
We therefore conclude that optimal nutrition may play a role in
the prevention of DM. However, our most disturbing finding
was the low reported micronutrient intakes of all three groups,
although underreporting in overweight and obese subjects
might have occurred. The need for better dietary education and
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Table I. Median nutrient intakes of the three groups
RDA
Nutrient Males Females NG group IGT group DM group
Vitamin A (µg RE) 1 000 800 236 235 154
Vitamin D (µg) 50 50 1.7 0.58 0.97
Vitamin E (mg α-TE) 10 8 5.5 4.2 4.1
Vitamin C (mg) 60 60 22 8.8 5.12
Thiamin (mg) 1.2 1.1 0.65 0.54 0.6
Riboflavin (mg) 1.3 1.1 0.71 0.62 0.56
Niacin (mg NE) 16 14 6.53 3.62 5.04
Vitamin B6 (mg) 1.9 1.7 0.6 0.4 0.5
Folate (µg) 400 400 129.1 91.3 128.1
Vitamin B12 (µg) 2.4 2.4 2.0 1.11 2.15
Calcium (mg) 800 800 323 294 280
Phosphorus (mg) 800 800 718 506 563
Magnesium (mg) 350 280 208 155 178
Iron (mg) 10 15 5.6 3.7 5.4
Zinc (mg) 15 12 6.7 4.0 4.2
RE = retinol equivalents; mg α-TE = tocopherol equivalents; NE =niacin equivalents.
